Correlation Between Vaccinex and Corvus Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Vaccinex and Corvus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vaccinex and Corvus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Vaccinex and Corvus Pharmaceuticals, you can compare the effects of market volatilities on Vaccinex and Corvus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vaccinex with a short position of Corvus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vaccinex and Corvus Pharmaceuticals.

Diversification Opportunities for Vaccinex and Corvus Pharmaceuticals

-0.49

Correlation Coefficient

Vaccinex  Corvus Pharmaceuticals

Very good diversification

The 3 months correlation between Vaccinex and Corvus is -0.49. Overlapping area represents the amount of risk that can be diversified away by holding Vaccinex and Corvus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Corvus Pharmaceuticals and Vaccinex is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vaccinex are associated (or correlated) with Corvus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Corvus Pharmaceuticals has no effect on the direction of Vaccinex i.e., Vaccinex and Corvus Pharmaceuticals go up and down completely randomly.

Pair Corralation between Vaccinex and Corvus Pharmaceuticals

Given the investment horizon of 90 days Vaccinex is expected to generate 1.29 times more return on investment than Corvus Pharmaceuticals. However, Vaccinex is 1.29 times more volatile than Corvus Pharmaceuticals. It trades about 0.29 of its potential returns per unit of risk. Corvus Pharmaceuticals is currently generating about 0.05 per unit of risk. If you would invest  279.00  in Vaccinex on September 1, 2024 and sell it today you would earn a total of  99.00  from holding Vaccinex or generate 35.48% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Vaccinex  vs.  Corvus Pharmaceuticals

Vaccinex

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Vaccinex has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Corvus Pharmaceuticals

Risk-Adjusted Performance

23 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Corvus Pharmaceuticals are ranked lower than 23 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Corvus Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Vaccinex and Corvus Pharmaceuticals

The main advantage of trading using opposite Vaccinex and Corvus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vaccinex position performs unexpectedly, Corvus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Corvus Pharmaceuticals will offset losses from the drop in Corvus Pharmaceuticals' long position.

The idea behind Vaccinex and Corvus Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.